Dr Srinivas Akkaraju
Srini Akkaraju is the Founder and Managing General Partner of Samsara BioCapital, a biotech-focused investment firm. He was formerly a General Partner of Sofinnova Ventures, Managing Director of New Leaf Venture Partners, Founding Managing Director at Panorama Capital, and Partner with JP Morgan Partners.
Srini has served as a Director on the boards of Seattle Genetics, Chinook Therapeutics, Intercept Pharmaceuticals, ZS Pharma, Eyetech Pharmaceuticals, Synageva Biopharma Corp, Barrier Therapeutics, and Amarin Corporation. He is currently a Director of Syros Pharmaceuticals, Scholar Rock, and Mineralys Therapeutics.
Srini joined the Board in February 2016 and is Chair of George Health Enterprises.